These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 25003011)
21. Pharmaceutical Chaperones and Proteostasis Regulators in the Therapy of Lysosomal Storage Disorders: Current Perspective and Future Promises. Mohamed FE; Al-Gazali L; Al-Jasmi F; Ali BR Front Pharmacol; 2017; 8():448. PubMed ID: 28736525 [TBL] [Abstract][Full Text] [Related]
22. Pressure for drug development in lysosomal storage disorders - a quantitative analysis thirty years beyond the US orphan drug act. Mechler K; Mountford WK; Hoffmann GF; Ries M Orphanet J Rare Dis; 2015 Apr; 10():46. PubMed ID: 25896727 [TBL] [Abstract][Full Text] [Related]
23. Combination Therapies for Lysosomal Storage Diseases: A Complex Answer to a Simple Problem. Macauley SL Pediatr Endocrinol Rev; 2016 Jun; 13 Suppl 1(Suppl 1):639-48. PubMed ID: 27491211 [TBL] [Abstract][Full Text] [Related]
24. Recent advances in gene therapy for lysosomal storage disorders. Rastall DP; Amalfitano A Appl Clin Genet; 2015; 8():157-69. PubMed ID: 26170711 [TBL] [Abstract][Full Text] [Related]
25. High proportion of mannosidosis and fucosidosis among lysosomal storage diseases in Cuba. Menéndez-Sainz C; González-Quevedo A; González-García S; Peña-Sánchez M; Giugliani R Genet Mol Res; 2012 Aug; 11(3):2352-9. PubMed ID: 22911605 [TBL] [Abstract][Full Text] [Related]
26. Treatment of lysosomal storage diseases: recent patents and future strategies. Ortolano S; Viéitez I; Navarro C; Spuch C Recent Pat Endocr Metab Immune Drug Discov; 2014 Jan; 8(1):9-25. PubMed ID: 24433521 [TBL] [Abstract][Full Text] [Related]
27. Enzyme enhancement therapeutics for lysosomal storage diseases: Current status and perspective. Thomas R; Kermode AR Mol Genet Metab; 2019 Feb; 126(2):83-97. PubMed ID: 30528228 [TBL] [Abstract][Full Text] [Related]
28. Novel biomarkers for lysosomal storage disorders: Metabolomic and proteomic approaches. Elmonem MA; Abdelazim AM Clin Chim Acta; 2020 Oct; 509():195-209. PubMed ID: 32561345 [TBL] [Abstract][Full Text] [Related]
29. Regulatory strategies for rare diseases under current global regulatory statutes: a discussion with stakeholders. Mulberg AE; Bucci-Rechtweg C; Giuliano J; Jacoby D; Johnson FK; Liu Q; Marsden D; McGoohan S; Nelson R; Patel N; Romero K; Sinha V; Sitaraman S; Spaltro J; Kessler V Orphanet J Rare Dis; 2019 Feb; 14(1):36. PubMed ID: 30736861 [TBL] [Abstract][Full Text] [Related]
31. Impact, Characterization, and Rescue of Pre-mRNA Splicing Mutations in Lysosomal Storage Disorders. Dardis A; Buratti E Genes (Basel); 2018 Feb; 9(2):. PubMed ID: 29415500 [TBL] [Abstract][Full Text] [Related]
32. From bedside to cell biology: a century of history on lysosomal dysfunction. Coutinho MF; Matos L; Alves S Gene; 2015 Jan; 555(1):50-8. PubMed ID: 25275857 [TBL] [Abstract][Full Text] [Related]
33. Epidemiology and diagnosis of lysosomal storage disorders; challenges of screening. Kingma SD; Bodamer OA; Wijburg FA Best Pract Res Clin Endocrinol Metab; 2015 Mar; 29(2):145-57. PubMed ID: 25987169 [TBL] [Abstract][Full Text] [Related]